University Library
  • Login
A gateway to Melbourne's research publications
Minerva Access is the University's Institutional Repository. It aims to collect, preserve, and showcase the intellectual output of staff and students of the University of Melbourne for a global audience.
View Item 
  • Minerva Access
  • Medicine, Dentistry & Health Sciences
  • Melbourne Medical School
  • Melbourne Medical School Collected Works
  • Melbourne Medical School Collected Works - Research Publications
  • View Item
  • Minerva Access
  • Medicine, Dentistry & Health Sciences
  • Melbourne Medical School
  • Melbourne Medical School Collected Works
  • Melbourne Medical School Collected Works - Research Publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

    Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer

    Thumbnail
    Download
    published version (2.248Mb)

    Citations
    Scopus
    Web of Science
    Altmetric
    32
    30
    Author
    Dushyanthen, S; Teo, ZL; Caramia, F; Savas, P; Mintoff, CP; Virassamy, B; Henderson, MA; Luen, SJ; Mansour, M; Kershaw, MH; ...
    Date
    2017-09-19
    Source Title
    Nature Communications
    Publisher
    NATURE PUBLISHING GROUP
    University of Melbourne Author/s
    Savas, Peter; Teo, Zhi Ling; Kershaw, Michael; Trapani, Joseph; Neeson, Paul; Darcy, Phillip; Loi, Sherene; Dushyanthen, Sathana; McArthur, Grant; Beavis, Paul; ...
    Affiliation
    Melbourne Medical School
    Sir Peter MacCallum Department of Oncology

    Clinical Pathology
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    Dushyanthen, S., Teo, Z. L., Caramia, F., Savas, P., Mintoff, C. P., Virassamy, B., Henderson, M. A., Luen, S. J., Mansour, M., Kershaw, M. H., Trapani, J. A., Neeson, P. J., Salgado, R., McArthur, G. A., Balko, J. M., Beavis, P. A., Darcy, P. K. & Loi, S. (2017). Agonist immunotherapy restores T cell function following MEK inhibition improving efficacy in breast cancer. NATURE COMMUNICATIONS, 8 (1), https://doi.org/10.1038/s41467-017-00728-9.
    Access Status
    Open Access
    URI
    http://hdl.handle.net/11343/256979
    DOI
    10.1038/s41467-017-00728-9
    NHMRC Grant code
    NHMRC/1041828
    NHMRC/1058388
    Abstract
    The presence of tumor-infiltrating lymphocytes in triple-negative breast cancers is correlated with improved outcomes. Ras/MAPK pathway activation is associated with significantly lower levels of tumor-infiltrating lymphocytes in triple-negative breast cancers and while MEK inhibition can promote recruitment of tumor-infiltrating lymphocytes to the tumor, here we show that MEK inhibition adversely affects early onset T-cell effector function. We show that α-4-1BB and α-OX-40 T-cell agonist antibodies can rescue the adverse effects of MEK inhibition on T cells in both mouse and human T cells, which results in augmented anti-tumor effects in vivo. This effect is dependent upon increased downstream p38/JNK pathway activation. Taken together, our data suggest that although Ras/MAPK pathway inhibition can increase tumor immunogenicity, the negative impact on T-cell activity is functionally important. This undesirable impact is effectively prevented by combination with T-cell immune agonist immunotherapies resulting in superior therapeutic efficacy.MEK inhibition in breast cancer is associated with increased tumour infiltrating lymphocytes (TILs), however, MAPK activity is required for T cells function. Here the authors show that TILs activity following MEK inhibition can be enhanced by agonist immunotherapy resulting in synergic therapeutic effects.

    Export Reference in RIS Format     

    Endnote

    • Click on "Export Reference in RIS Format" and choose "open with... Endnote".

    Refworks

    • Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References


    Collections
    • Minerva Elements Records [53102]
    • Clinical Pathology - Research Publications [620]
    • Sir Peter MacCallum Department of Oncology - Research Publications [1023]
    • Melbourne Medical School Collected Works - Research Publications [502]
    Minerva AccessDepositing Your Work (for University of Melbourne Staff and Students)NewsFAQs

    BrowseCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    My AccountLoginRegister
    StatisticsMost Popular ItemsStatistics by CountryMost Popular Authors